Chemical Compound

Streptolydigin

CAS Registry Number 7229-50-7
Back to search Request a Quote
Streptolydigin chemical structure
Primary Record

Streptolydigin

In stock
7,155 g
Purity
98.9 %
CAS
7229-50-7

Compound Identifiers & Properties

CAS
7229-50-7
PubChem CID
54708748
SMILES
C[C@H]1[C@H]2C=C[C@@]3(CO3)[C@](O2)(O[C@@H]1[C@H](C)/C=C(\C)/C=C/C(=C\4/C(=O)[C@@H](N(C4=O)[C@@H]5CC[C@@H]([C@@H](O5)C)O)[C@H](C)C(=O)NC)/O)C
Canonical SMILES
CNC(=O)[C@@H](C)[C@H]1C(=O)/C(=C(O)/C=C/C(C)=C/[C@@H](C)[C@H]2O[C@@]3(C)O[C@H](C=C[C@@]34CO4)[C@@H]2C)C(=O)N1[C@@H]1CC[C@H](O)[C@H](C)O1

Names & Synonyms

  • Streptolydigin
  • Portamycin
  • Antibiotic D-45
  • Afragilimycin A
  • Free acid
  • 1zyr
  • RefChem:185937
  • NSC 3360
  • STREPTOLYDIGIN [MI]
  • AC1NRD97
  • 6MON4029Q8
  • CHEBI:45773
  • UNII-6MON4029Q8
  • DTXSID20905083
  • KVTPRMVXYZKLIG-NCAOFHFGSA-N
  • orb1706596
  • 7229-50-7
  • CHEMBL1236068
  • NSC-3360
  • SCHEMBL29395027
  • DTXCID001334185
  • BBF-03486
  • AKOS040742653
  • CID5289413
  • DB04785
  • 2-PYRROLIDINEACETAMIDE; PORTAMYCIN
  • DA-67812
  • J37.255B
  • HY-122337
  • LS-147048
  • CS-0083992
  • NS00073491
  • Q5849706
  • (2S)-2-[(2S,4E)-4-[(2E,4E,6R)-6-[(1R,3R,4S,5R,8R)-1,4-dimethylspiro[2,9-dioxabicyclo[3.3.1]non-6-ene-8,2'-oxirane]-3-yl]-1-hydroxy-4-methylhepta-2,4-dienylidene]-1-[(2S,5S,6S)-5-hydroxy-6-methyloxan-2-yl]-3,5-dioxopyrrolidin-2-yl]-N-methylpropanamide
  • (2S)-2-{(2S,4E)-4-{(2E,4E,6R)-6-[(1R,2R,5R,6S,7R)-1,6-dimethylspiro[8,9-dioxabicyclo[3.3.1]non-3-ene-2,2'-oxiran]-7-yl]-1-hydroxy-4-methylhepta-2,4-dien-1-ylidene}-1-[(2S,5S,6S)-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]-3,5-dioxopyrrolidin-2-yl}-N-methylpropanamide
  • 3-Pyrroline-2-acetamide, 4-(6-(1,4-dimethylspiro(2,9-dioxabicyclo(3.3.1)non-6-ene-8,2'-oxiran)-3-yl)-4-methyl-2,4-heptadienoyl)-3-hydroxy-N,alpha-dimethyl-5-oxo-1-(tetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)- (VAN)
  • STD
  • (2S)-2-((2S,4E)-4-((2E,4E,6R)-6-((1R,2S,3R,5R,6R)-2,5-dimethylspiro(4,9-dioxabicyclo(3.3.1)non-7-ene-6,2'-oxirane)-3-yl)-1-hydroxy-4-methylhepta-2,4-dienylidene)-1-((2S,5S,6S)-5-hydroxy-6-methyloxan-2-yl)-3,5-dioxopyrrolidin-2-yl)-N-methylpropanamide
  • (2S)-2-((2S,4E)-4-((2E,4E,6R)-6-((1R,3R,4S,5R,8R)-1,4-dimethylspiro(2,9-dioxabicyclo(3.3.1)non-6-ene-8,2'-oxirane)-3-yl)-1-hydroxy-4-methylhepta-2,4-dienylidene)-1-((2S,5S,6S)-5-hydroxy-6-methyloxan-2-yl)-3,5-dioxopyrrolidin-2-yl)-N-methylpropanamide
  • (2S)-2-[(2S)-4-[(2E,4E,6R)-6-[(1R,2S,3R,5R,6R)-2,5-dimethylspiro[4,9-dioxabicyclo[3.3.1]non-7-ene-6,2'-oxirane]-3-yl]-4-methylhepta-2,4-dienoyl]-5-hydroxy-1-[(2S,5S,6S)-5-hydroxy-6-methyloxan-2-yl]-3-oxo-2H-pyrrol-2-yl]-N-methylpropanamide
  • (2S)-2-[(2S,4E)-4-[(2E,4E,6R)-6-[(1R,2R,5R,6S,7R)-1,6-dimethyl-8,9-dioxaspiro[bicyclo[3.3.1]nonane-2,2'-oxiran]-3-en-7-yl]-1-hydroxy-4-methylhepta-2,4-dien-1-ylidene]-1-[(2S,5S,6S)-5-hydroxy-6-methyloxan-2-yl]-3,5-dioxopyrrolidin-2-yl]-N-methylpropanamide
  • (2S)-2-{(2S,4E)-4-{(2E,4E,6R)-6-[(1R,2R,5R,6S,7R)-1,6-Dimethylspiro[8,9-dioxabicyclo[3.3.1]non-3-ene-2,2'-oxiran]-7-yl]-1-hydroxy-4-methylhepta-2,4-dien-1-ylidene}-1-[(2S,5S,6S)-5-hydroxy-6-methyloxan-2-yl]-3,5-dioxopyrrolidin-2-yl}-N-methylpropanamide
  • 2-PYRROLIDINEACETAMIDE, 4-[6-(1,4-DIMETHYLSPIRO[2,9-DIOXABICYCLO[3.3.1]NON-6-ENE-8,2'-OXIRAN-3-YL)-1-HYDROXY-4-METHYL-2,4-HEPTADIENYLIDENE]-N,ALPHA-DIMETHYL-3,5-DIOXO-1-(TETRAHYDRO-5-HYDROXY-6-METHYL-2H-PYRAN-2-YL)-
  • 2-Pyrrolidineacetamide,4-[(2E,4E,6R)-6-[(1R,2'R,3R,4S,5R)-1,4-dimethylspiro[2,9-dioxabicyclo[3.3.1]non-6-ene-8,2'-oxiran]-3-yl]-1-hydroxy-4-methyl-2,4-heptadien-1-ylidene]-N,a-dimethyl-3,5-dioxo-1-[(2S,5S,6S)-tetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl]-,